MY ACCOUNT | NEWSLETTER |

College merges Departments of Biomedical Sciences and Molecular Medicine, creating Department of Biomedical and Translational Sciences


Cornell University’s College of Veterinary Medicine (CVM) today announced the merger of the Department of Biomedical Sciences (BMS) and the Department of Molecular Medicine (MM) to form the Department of Biomedical and Translational Sciences (BTS). The new department aligns foundational biological discovery with disease-focused translational research, while strengthening D.V.M., graduate and undergraduate education and streamlining operations. Dr. Praveen Sethupathy, ’03, former chair of BMS, will lead the new department.

“This merger brings together two highly successful and complementary communities,” said Lorin D. Warnick, D.V.M., Ph.D.’94, the Austin O. Hooey Dean of Veterinary Medicine. “I am grateful that Dr. Sethupathy has accepted the important role of overseeing this new department and I thank him and Molecular Medicine interim chair Toshi Kawate for leading the planning efforts. I am looking forward to the collaborations that will emerge from the new department’s strengths in both cell and molecular biology and physiology and animal models of disease.” 

A multi-step merger

Sethupathy and Kawate led a rigorous, multi-step process in joining their two departments. During the 2024 calendar year, “We held numerous brainstorming sessions, conducted community surveys, and led conversations with our faculty and staff to outline the rationale, review the potential benefits and concerns, and provide open forums for discussion,” said Sethupathy. “It was very important to us to make sure that everyone’s voice was heard and carefully considered.” By early 2025, the idea was approved at the college to move forward with a formal proposal to the university leadership, including detailed planning for both academic and administrative integration of the two departments. Kawate said, “The merged department has several clear goals around research synergy and educational streamlining.”

A strategic alignment of scientific strengths

The new department has 45 faculty members, including 28 tenure-track and 17 research, teaching and extension faculty. The merger brings together long shared overlapping areas of scientific inquiry, particularly in genetics and genomics, cell and developmental biology, and cancer biology. Kawate said the merger “Dissolves artificial boundaries and fosters greater capacity for discovery,” including the potential development of interdisciplinary teams to pursue ambitious and innovative projects. Veterinarians in the Center for Animal Resources and Education (CARE), who were adjunct faculty in the former Biomedical Sciences department, will continue in that capacity in the new department.

Enhancing the educational mission

With the merger, BTS will oversee the first three Foundation Courses in the D.V.M. curriculum, thus streamlining operations. “Bringing these foundation courses under one administrative umbrella provides the opportunity to enhance coordination among course leaders,” said Sethupathy. “The merged department will also offer strength in numbers and expertise to develop and implement new undergraduate courses that fill important instructional gaps, notably in cancer biology.”

“With its official launch, the BTS Department is well-poised to hit the ground running,” said Warnick. He added the new department will continue to foster strong collaborations with colleagues across the Ithaca campus and with Weill Cornell Medicine. Sethupathy added, “I am excited for this united community of faculty, staff and trainees to help advance the research and educational missions of the college. I am particularly grateful for the members of the administrative team, university colleagues, and the faculty, staff and students who provided input that has been crucial to the merger preparations. This work provides an excellent foundation for the future success of Biomedical and Translational Sciences.”


Author: Lauren Cahoon Roberts

Source: https://www.vet.cornell.edu/

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Meet Dr. Stephanie Maciorowski

Like0
Dislike0

Parnell Launches Pentobarbital Sodium and Phenytoin Sodium Euthanasia Solution for Dogs

Like0
Dislike0

Implementing a successful senior/geriatric health care program for veterinarians, veterinary technicians, and office managers

Like0
Dislike0

Malassezia species and its significance in canine skin disease

Like0
Dislike0

Assessment of serum amyloid A testing of horses and its clinical application in a specialized equine practice

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top